156 related articles for article (PubMed ID: 38223878)
21. Approach to the diagnosis of neuroendocrine lung neoplasms: variabilities and pitfalls.
Hammar SP
Semin Thorac Cardiovasc Surg; 2006; 18(3):183-90. PubMed ID: 17185177
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine Tumors of the Lung: Updates and Diagnostic Pitfalls.
Hung YP
Surg Pathol Clin; 2019 Dec; 12(4):1055-1071. PubMed ID: 31672294
[TBL] [Abstract][Full Text] [Related]
23. [Advances of pathological diagnosis and molecular pathology of lung neuroendocrine neoplasms].
Wu JH; Zhu YL; Wang HY; Liu YH; Lin DM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):109-115. PubMed ID: 38281776
[TBL] [Abstract][Full Text] [Related]
24. High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms.
Motylewska E; Braun M; Stępień H
Endocr Pathol; 2020 Sep; 31(3):264-273. PubMed ID: 32504181
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
[TBL] [Abstract][Full Text] [Related]
26. Lung cancer cytology and small biopsy specimens: diagnosis, predictive biomarker testing, acquisition, triage, and management.
Sung S; Heymann JJ; Crapanzano JP; Moreira AL; Shu C; Bulman WA; Saqi A
J Am Soc Cytopathol; 2020; 9(5):332-345. PubMed ID: 32591241
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
Gálffy G
Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
[TBL] [Abstract][Full Text] [Related]
28. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
30. Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma.
Baykara Y; Xiao Y; Yang D; Yakirevich E; Maleki S; Garcia-Moliner M; Wang LJ; Huang CK; Lu S
Virchows Arch; 2022 Jul; 481(1):31-39. PubMed ID: 35357570
[TBL] [Abstract][Full Text] [Related]
31. [Neuroendocrine lung tumors].
Ranfaing E
Ann Pathol; 1993; 13(6):414-21. PubMed ID: 8141935
[No Abstract] [Full Text] [Related]
32. [Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].
Li F; Zhong Z; Li R; Huang H; Wang L; Zheng D; Zhang D
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):317-21. PubMed ID: 20677557
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle.
Derks JL; Speel EJ; Thunnissen E; van Suylen RJ; Buikhuisen WA; van Velthuysen ML; Dingemans AM
J Thorac Oncol; 2016 Mar; 11(3):e35-8. PubMed ID: 26723240
[TBL] [Abstract][Full Text] [Related]
34. Primary Breast Neuroendocrine Tumor.
Jones VM; Cairns A; Chiba A; Howard-McNatt M
Am Surg; 2022 Aug; 88(8):1898-1900. PubMed ID: 35333626
[TBL] [Abstract][Full Text] [Related]
35. [Research advance on non-small cell lung carcinoma with neuroendocrine differentiation].
Dai Y; Han B
Zhongguo Fei Ai Za Zhi; 2011 Feb; 14(2):165-9. PubMed ID: 21342649
[No Abstract] [Full Text] [Related]
36. The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas.
Lee H; Fu Z; Koo BH; Sheehan CE; Young GQ; Lin J; Patil DT; Yang Z
Ann Diagn Pathol; 2018 Dec; 37():30-34. PubMed ID: 30236546
[TBL] [Abstract][Full Text] [Related]
37. [Lung tumours under the microscope].
Wiechmann V
MMW Fortschr Med; 2007 Nov; 149(44):27-9. PubMed ID: 18078166
[TBL] [Abstract][Full Text] [Related]
38. Clinical impact of mixed pulmonary carcinoma and carcinoid: the driver from their mono-clonal origin.
Graziano P; Parente P; Centra F; Milione M; Centonze G; Volante M; Cavazza A; Urbano D; Di Maggio G; Balsamo T; Di Micco C; Rossi G; Rossi A; Muscarella LA
Virchows Arch; 2024 Jan; 484(1):37-46. PubMed ID: 37773451
[TBL] [Abstract][Full Text] [Related]
39. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications.
Cagle PT; el-Naggar AK; Xu HJ; Hu SX; Benedict WF
Am J Pathol; 1997 Feb; 150(2):393-400. PubMed ID: 9033254
[TBL] [Abstract][Full Text] [Related]
40. Differential distribution of the neuron-associated class III beta-tubulin in neuroendocrine lung tumors.
Katsetos CD; Kontogeorgos G; Geddes JF; Herman MM; Tsimara-Papastamatiou H; Yu Y; Sakkas LI; Tsokos M; Patchefsky AS; Ehya H; Cooper HS; Provencio J; Spano AJ; Frankfurter A
Arch Pathol Lab Med; 2000 Apr; 124(4):535-44. PubMed ID: 10747310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
